ask="N/A"
ask_size="N/A"
average_daily_volume="21012"
bid="N/A"
bid_size="N/A"
book_value="0.452"
change="-0.075"
change_from_200_day_moving_average="0.130"
change_from_50_day_moving_average="0.107"
change_from_52_week_high="-1.365"
change_From_52_week_low="2.075"
change_in_percent="-1.875%"
close="3.925"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.443"
ebitda="-14.69M"
eps_estimate_current_year="-1.690"
eps_estimate_next_quarter="-0.020"
eps_estimate_next_year="-0.250"
ex_dividend_date="N/A"
float_shares="4889000"
high="3.950"
high_52_weeks="5.290"
last_trade_date="2/23/2017"
last_trade_price="3.925"
last_trade_size="100"
last_trade_time="4:02pm"
low="3.900"
low_52_weeks="1.850"
market_capitalization="59.40M"
moving_average_200_day="3.795"
moving_average_50_day="3.818"
name="NovaBay Pharmaceuticals
Inc. C"
notes="N/A"
one_year_target_price="6.750"
open="3.934"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+3.417%"
percent_change_from_50_day_moving_average="+2.804%"
percent_change_from_52_week_high="-25.803%"
percent_change_from_52_week_low="+112.162%"
previous_close="4.000"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.850"
price_per_sales="6.403"
revenue="9.45M"
shares_outstanding="15134000"
short_ratio="6.330"
stock_exchange="ASE"
symbol="NBY"
volume="6040"
weeks_range_52="1.850 - 5.290"
